SOA Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Sell
4,566
-13,215
-74% -$2.84M 0.05% 178
2026
Q1
$277K Buy
17,781
+112
+0.6% +$24.8K 0.05% 163
2025
Q4
$265K Sell
17,669
-9
-0.1% -$2.05K 0.04% 173
2025
Q3
$270K Buy
17,678
+1
+0% +$204 0.05% 172
2025
Q2
$220K Buy
17,677
+3,447
+24% +$641K 0.04% 190
2025
Q1
$202K Buy
14,230
+13,330
+1,481% +$2.59M 0.04% 186
2024
Q4
$160K Sell
900
-479
-35% -$88.1K 0.03% 207
2024
Q3
$272K Buy
1,379
+1
+0.1% +$187 0.05% 154
2024
Q2
$236K Sell
1,378
-476
-26% -$78.8K 0.05% 165
2024
Q1
$338K Buy
1,854
+6
+0.3% +$1.03K 0.07% 132
2023
Q4
$286K Buy
1,848
+6
+0.3% +$875 0.06% 141
2023
Q3
$275K Buy
1,842
+5
+0.3% +$734 0.07% 137
2023
Q2
$247K Buy
1,837
+6
+0.3% +$880 0.06% 145
2023
Q1
$292K Buy
1,831
+64
+4% +$9.79K 0.07% 125
2022
Q4
$286K Sell
1,767
-9
-0.5% -$1.38K 0.08% 123
2022
Q3
$238K Sell
1,776
-70
-4% -$10K 0.07% 132
2022
Q2
$282K Sell
1,846
-399
-18% -$61K 0.08% 120
2022
Q1
$364K Buy
2,245
+5
+0.2% +$726 0.09% 115
2021
Q4
$304K Buy
2,240
+6
+0.3% +$709 0.07% 129
2021
Q3
$241K Buy
2,234
+4
+0.2% +$457 0.06% 137
2021
Q2
$251K Buy
2,230
+222
+11% +$25K 0.06% 137
2021
Q1
$217K Buy
2,008
+132
+7% +$14.1K 0.06% 136
2020
Q4
$195K Buy
+1,876
New +$180K 0.05% 136

Other funds holding ABBV

SOA Wealth Advisors's ABBV Position: Q2 2026 in Review

SOA Wealth Advisors reduced its AbbVie (ABBV) stake by 74% in Q2 2026, selling an estimated $2.84M and leaving 4,566 shares worth $276K. The position accounts for 0.05% of the portfolio, ranked #178.

SOA Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $364K in Q1 2022. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SOA Wealth Advisors held 4,566 shares of AbbVie worth $276K as of Q2 2026.
  • SOA Wealth Advisors sold 13,215 AbbVie shares in Q2 2026, an estimated $2.84M.
  • AbbVie made up 0.05% of SOA Wealth Advisors's portfolio in Q2 2026, its #178 holding.
  • SOA Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's AbbVie position peaked at $364K in Q1 2022.
  • 1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.